enoxacin has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, L | 2 |
| Zhou, J | 2 |
| Meng, F | 1 |
| Fu, C | 2 |
| Zou, X | 1 |
| Liu, J | 1 |
| Zhang, C | 1 |
| Tan, R | 1 |
| Li, Z | 2 |
| Guo, Q | 2 |
| Wei, L | 2 |
| Yuan, Y | 1 |
| Xu, X | 1 |
| Wang, S | 1 |
| Kong, L | 1 |
2 other studies available for enoxacin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Enoxacin; G1 Phase Cell Cycle | 2019 |
LZ-106, a novel analog of enoxacin, inducing apoptosis via activation of ROS-dependent DNA damage response in NSCLCs.
Topics: Acetylcysteine; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; | 2016 |